12-July-2021
To commemorate the 10th anniversary of Akceso Advisors we have collected a few facts and figures, demonstrating the successes and milestones.
Enjoy this little video and explore more on the anniversary page.
Read the recent posts in our blog
April 2nd Tariffs Proclamation Increases Pressure on US Pharma Imports
On April 2, 2026, President Trump imposed 100% tariffs under Section 232 on patented pharmaceuticals and APIs. Exemptions for generics, MFN agreements, and onshoring. Impact on US imports analysed.
Faces Behind the Tools: Dávid and Szabolcs, Akceso’s Newest Techie Pillars for IRP and MFN Excellence
We are happy to introduce Dávid and Szabolcs, the two newest members of our Techie team, both joined recently in 2025.
Akceso Advisors elects Dr. Seng Chin Mah as Board Member
Akceso Advisors AG, a leading independent global advisory firm specializing in market access, pricing, reimbursement strategy, operations and policy-setting for life-science companies and authorities, announced today the election of Dr. Seng Chin Mah as a new non‑executive member of its Board of Directors.
Mind the communication gap in patient access
Read the story of how the clear communication unlocked the market access potential of an innovative product for our client.
